195 related articles for article (PubMed ID: 16438098)
81. Use of interactive voice response to improve colorectal cancer screening.
Cohen-Cline H; Wernli KJ; Bradford SC; Boles-Hall M; Grossman DC
Med Care; 2014 Jun; 52(6):496-9. PubMed ID: 24638119
[TBL] [Abstract][Full Text] [Related]
82. Receipt of colorectal testing prior to colorectal carcinoma diagnosis.
Cooper GS; Payes JD
Cancer; 2005 Feb; 103(4):696-701. PubMed ID: 15643638
[TBL] [Abstract][Full Text] [Related]
83. Colon cancer screening practices in New York City, 2003: results of a large random-digit dialed telephone survey.
Thorpe LE; Mostashari F; Hajat A; Nash D; Karpati A; Weber T; Winawer S; Neugut AI; Awad A; Zevallos M; Remy P; Frieden T;
Cancer; 2005 Sep; 104(5):1075-82. PubMed ID: 16044401
[TBL] [Abstract][Full Text] [Related]
84. Use of lower gastrointestinal endoscopy and fecal occult blood test in the 2007 Swiss Health Interview Survey respondents aged 50 years and older.
Spaeth A; Zwahlen M
Endoscopy; 2013 Jul; 45(7):560-6. PubMed ID: 23780844
[TBL] [Abstract][Full Text] [Related]
85. Colorectal screening practices in Kentucky.
Tucker TC; Huang B; Klinglesmith RE; Tuckson WB;
J Ky Med Assoc; 2005 Aug; 103(8):349-53. PubMed ID: 16134428
[No Abstract] [Full Text] [Related]
86. Understanding racial and ethnic disparities in colorectal cancer screening: Behavioral Risk Factor Surveillance System, 2002 and 2004.
Crawford ND; Jones CP; Richardson LC
Ethn Dis; 2010; 20(4):359-65. PubMed ID: 21305822
[TBL] [Abstract][Full Text] [Related]
87. Is routine screening for colorectal cancer justifiable? This gastroenterologist says NO!
Koretz RL
Postgrad Med; 1997 Jul; 102(1):49, 53-5, 60-2. PubMed ID: 9254390
[TBL] [Abstract][Full Text] [Related]
88. Fecal occult blood test use by Kansas medicare beneficiaries.
Engelman KK; Ellerbeck EF; Ahluwalia JS; Nazir N; Velasco A
Prev Med; 2001 Dec; 33(6):622-6. PubMed ID: 11716659
[TBL] [Abstract][Full Text] [Related]
89. Trends and Determinants of Up-to-date Status with Colorectal Cancer Screening in Tennessee, 2002-2008.
Veeranki SP; Zheng S
Int J Prev Med; 2014 Jul; 5(7):865-74. PubMed ID: 25104998
[TBL] [Abstract][Full Text] [Related]
90. Factors Associated with Colorectal Cancer Screening among Mississippi Adults: Findings from the Behavioral Risk Factor Surveillance System.
Zhang WQ; Tang SJ; Dobbs TE; Zhang L
South Med J; 2020 Jul; 113(7):360-365. PubMed ID: 32617599
[TBL] [Abstract][Full Text] [Related]
91. Colorectal cancer screening in North Carolina. Community clinicians' perspectives.
O'Malley MS; Shaheen NJ; Crosby MA; Murray SC; Klenzak JS; Galanko JA; Singla A; Ransohoff DF; Sandler RS; Gaither J; Paskett ED
N C Med J; 2001; 62(5):292-7. PubMed ID: 11570329
[No Abstract] [Full Text] [Related]
92. Vital signs: colorectal cancer screening test use--United States, 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Nov; 62(44):881-8. PubMed ID: 24196665
[TBL] [Abstract][Full Text] [Related]
93. Understanding Barriers to Colorectal Cancer Screening in Kentucky.
Knight JR; Kanotra S; Siameh S; Jones J; Thompson B; Thomas-Cox S
Prev Chronic Dis; 2015 Jun; 12():E95. PubMed ID: 26086608
[TBL] [Abstract][Full Text] [Related]
94. "Fault-line of an earthquake": a qualitative examination of barriers and facilitators to colorectal cancer screening in rural, Eastern North Carolina.
Jilcott Pitts SB; Lea CS; May CL; Stowe C; Hamill DJ; Walker KT; Fitzgerald TL
J Rural Health; 2013; 29(1):78-87. PubMed ID: 23289658
[TBL] [Abstract][Full Text] [Related]
95. Predictors of older adults' participation in fecal occult blood screening.
Weinrich SP
Oncol Nurs Forum; 1990; 17(5):715-20. PubMed ID: 2251189
[TBL] [Abstract][Full Text] [Related]
96. Trends in colorectal cancer test use among vulnerable populations in the United States.
Klabunde CN; Cronin KA; Breen N; Waldron WR; Ambs AH; Nadel MR
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1611-21. PubMed ID: 21653643
[TBL] [Abstract][Full Text] [Related]
97. An automated data algorithm to distinguish screening and diagnostic colorectal cancer endoscopy exams.
Haque R; Chiu V; Mehta KR; Geiger AM
J Natl Cancer Inst Monogr; 2005; (35):116-8. PubMed ID: 16287897
[TBL] [Abstract][Full Text] [Related]
98. Diabetes Status and Being Up-to-Date on Colorectal Cancer Screening, 2012 Behavioral Risk Factor Surveillance System.
Porter NR; Eberth JM; Samson ME; Garcia-Dominic O; Lengerich EJ; Schootman M
Prev Chronic Dis; 2016 Feb; 13():E19. PubMed ID: 26851338
[TBL] [Abstract][Full Text] [Related]
99. Modifying attributions of colorectal cancer risk.
Lipkus IM; Skinner CS; Green LS; Dement J; Samsa GP; Ransohoff D
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):560-6. PubMed ID: 15066920
[TBL] [Abstract][Full Text] [Related]
100. Prevalence of colorectal cancer screening among adults--Behavioral Risk Factor Surveillance System, United States, 2010.
Joseph DA; King JB; Miller JW; Richardson LC;
MMWR Suppl; 2012 Jun; 61(2):51-6. PubMed ID: 22695464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
